Adults receiving semaglutide as their first obesity medication lose more weight
Adults with obesity lost more weight with semaglutide if they did not use another obesity medication in the past.
Adults with obesity lost more weight with semaglutide if they did not use another obesity medication in the past.
For patients with obesity, weight management treatments (WMTs) are associated with an increased probability of 5 percent or greater weight loss, according to a study published online Feb. 15 in JAMA Network Open.
An experimental study looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides).
New research to be presented at this year's European Congress on Obesity (Venice, Italy, May 12-15) shows that the obesity medication tirzepatide consistently reduces body weight and waist circumference regardless of the length of time the person has been living with overweight or obesity.
Postmenopausal women on hormone therapy had higher total body weight loss with semaglutide for up to 12 months vs. no hormone therapy.